Baxano, a developer of surgical technology for restoring spinal function, has secured $30m in a series C round. The financing brought in three new investors, Kaiser Permanente Ventures, Affinity Capital Management and CMEA Capital, which led the round. Baxano's existing shareholders also ...
Please Login to read the full article.
